Sign in
Taking people in ItalyPhase 4

Comparing two sedation drugs during endoscopic ultrasound for stomach or pancreatic cancer

Tests remimazolam against propofol to keep adults calm during endoscopic ultrasound.

Key facts

Who runs it
Ospedale San Raffaele S.r.l.
Where
Milan, ItalySee the site
Registry title
Remimazolam versus propofol for deep sedation during Endoscopic Ultrasound (EUS) procedures. A randomized controlled trial.
Status
Recruiting
Phase
Phase 4
People taking part
332 people, planned
Started
23 Jun 2026
Planned end
31 Jul 2026
Type of study
Interventional
Record updated
10 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who are booked for a planned endoscopic ultrasound of the digestive tract as outpatients. It compares two ways of giving deep sedation.

Age
Over 18 years
Sex
All sexes can join

Main reasons for not taking part

  • Urgent endoscopic ultrasound procedures
  • Known reasons why propofol or remimazolam cannot be used
  • Procedures that need a breathing tube through the mouth
  • Pregnant or breastfeeding women
  • Inpatient procedures

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Patients >18 years
  • Patients scheduled for elective EUS gastrointestinal procedures
  • Signed informed consent
  • Outpatient procedures

Who cannot take part

  • Patients < 18 years
  • Patients scheduled for urgent EUS gastrointestinal procedures
  • Known contraindications to the use of propofol and/or remimazolam
  • Patient’s refusal to participate
  • Procedures that require orotracheal intubation
  • Pregnant and breastfeeding women
  • Inpatient procedures

This trial is currently available in Italy.

  • Ospedale San Raffaele S.r.l.Milan, ItalyTaking people

About the trial

What the trial wants to find out

To compare a remimazolam-based sedation regimen managed by endoscopists to a propofol-based sedation regimen performed by anesthesiologists during EUS gastrointestinal procedures.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
Remimazolam versus propofol for deep sedation during Endoscopic Ultrasound (EUS) procedures. A randomized controlled trial.
Plain-language title
Comparing two sedation drugs during endoscopic ultrasound for stomach or pancreatic cancerGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
10 September 2026